Dalton Pharma Services Expands its Contract Analytical Services
Dalton Pharma Services is pleased to announce the expansion of its Contract - Analytical Services with the commissioning of two validated LC-MS/MS instruments which have been qualified for GMP testing of pharmaceutical products.
TORONTO, July 15 /CNW/ - Dalton Pharma Services is pleased to announce the expansion of its Contract - Analytical Services with the commissioning of two validated LC-MS/MS instruments which have been qualified for GMP testing of pharmaceutical products. The new equipment will assist in the identification, quantification of related substances, pharmaceutical degradation products, and impurities to support the preparation of registration dossiers for clients' drug development programs.
"Our commitment to accelerate the drug discover and development process continues as we add to our state-of-the -art instrumentation to support GMP API synthesis, sterile dose formulation and sterile fill method validation and other outsourced analytical projects including stability studies, bioanalytical development and analysis," said Peter Pekos, President and CEO.
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton Provides cGMP manufacturing and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities,
For Further information: Peter Pekos, President & CEO, Dalton Pharma Services,
Tel: (416) 661-2102, Fax: (416) 661-2108